Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial
Sign Up to like & getrecommendations! Published in 2022 at "Trials"
DOI: 10.1186/s13063-022-06200-4
Abstract: Background Lumbrokinase has been widely used for patients with acute ischemic stroke (AIS) in China; however, because rigorously designed studies are lacking, safety and efficacy of lumbrokinase in the treatment of acute ischemic stroke remains… read more here.
Keywords: acute ischemic; plus aspirin; ischemic stroke; lumbrokinase plus ... See more keywords